Cynosure Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
2,034
+367
| +22% | +$286K | 0.18% | 58 |
|
|
2025
Q1 | $1.38M | Buy |
1,667
+107
| +7% | +$88.4K | 0.19% | 57 |
|
|
2024
Q4 | $1.2M | Sell |
1,560
-562
| -26% | -$434K | 0.18% | 63 |
|
|
2024
Q3 | $1.88M | Buy |
2,122
+379
| +22% | +$336K | 0.27% | 47 |
|
|
2024
Q2 | $1.58M | Buy |
1,743
+16
| +0.9% | +$14.5K | 0.25% | 56 |
|
|
2024
Q1 | $1.34M | Buy |
1,727
+775
| +81% | +$603K | 0.24% | 49 |
|
|
2023
Q4 | $555K | Buy |
952
+64
| +7% | +$37.3K | 0.1% | 116 |
|
|
2023
Q3 | $477K | Buy |
+888
| New | +$477K | 0.15% | 111 |
|